Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A population-based approach to chemotherapy-induced peripheral neuropathy reveals the disease burden of early and late effects
Neuromuscular and Clinical Neurophysiology (EMG)
P5 - (-)
117
Authors/Disclosures
Arya Shah (Mayo Medical School)
PRESENTER 		No disclosure on file
E. M. Hoffman, DO, PhD (Mayo Clinic, Neurology) Dr. Hoffman has nothing to disclose.
Christopher J. Klein, MD, FÂ鶹´«Ã½Ó³»­ (Mayo Clinic) Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Nathan P. Staff, MD, PhD, FÂ鶹´«Ã½Ó³»­ (Mayo Clinic) Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.